Total Payments
$132,503
2024 Payments
$30,734
Companies
2
Transactions
97
Medicare Patients
409
Medicare Billing
$108,394
Payment Breakdown by Category
Other$117,236 (88.5%)
Travel$8,656 (6.5%)
Consulting$3,515 (2.7%)
Food & Beverage$2,989 (2.3%)
Education$107.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $95,164 | 25 | 71.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,073 | 8 | 16.7% |
| Travel and Lodging | $8,656 | 21 | 6.5% |
| Consulting Fee | $3,515 | 2 | 2.7% |
| Food and Beverage | $2,989 | 39 | 2.3% |
| Education | $107.00 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $132,474 | 96 | $0 (2024) |
| AbbVie Inc. | $29.34 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $30,734 | 15 | La Jolla Pharmaceutical Company ($30,734) |
| 2023 | $28,833 | 16 | La Jolla Pharmaceutical Company ($28,804) |
| 2022 | $32,520 | 19 | La Jolla Pharmaceutical Company ($32,520) |
| 2021 | $5,855 | 2 | La Jolla Pharmaceutical Company ($5,855) |
| 2020 | $3,812 | 7 | La Jolla Pharmaceutical Company ($3,812) |
| 2019 | $5,734 | 16 | La Jolla Pharmaceutical Company ($5,734) |
| 2018 | $25,015 | 22 | La Jolla Pharmaceutical Company ($25,015) |
All Payment Transactions
97 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/30/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Honoraria | Cash or cash equivalent | $3,639.00 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 09/30/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $113.71 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 07/30/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Honoraria | Cash or cash equivalent | $7,277.00 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 07/30/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Travel and Lodging | Cash or cash equivalent | $163.75 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 07/30/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $120.61 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 06/20/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Honoraria | Cash or cash equivalent | $3,119.00 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 02/27/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Honoraria | Cash or cash equivalent | $7,277.00 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 02/27/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Honoraria | Cash or cash equivalent | $3,119.00 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 02/27/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Travel and Lodging | Cash or cash equivalent | $114.99 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 02/27/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $96.35 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 02/27/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 01/30/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Honoraria | Cash or cash equivalent | $5,198.00 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 01/30/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Travel and Lodging | Cash or cash equivalent | $358.20 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 01/30/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $112.98 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 01/10/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $3.83 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 06/22/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Travel and Lodging | Cash or cash equivalent | $368.82 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 06/22/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $117.75 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 06/21/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Travel and Lodging | Cash or cash equivalent | $352.57 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 06/21/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $69.75 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 06/21/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $66.28 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 06/07/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Honoraria | Cash or cash equivalent | $7,277.00 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 05/25/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Honoraria | Cash or cash equivalent | $3,639.00 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 05/24/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Honoraria | Cash or cash equivalent | $7,277.00 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 05/24/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Travel and Lodging | Cash or cash equivalent | $975.38 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 05/10/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $111.56 | General |
| Category: EMERGENT HYPOTENSION | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 91 | 207 | $273,845 | $28,975 |
| 2022 | 5 | 131 | 260 | $362,155 | $37,420 |
| 2021 | 4 | 94 | 138 | $217,650 | $21,038 |
| 2020 | 5 | 93 | 138 | $222,300 | $20,961 |
Total Patients
409
Total Services
743
Medicare Billing
$108,394
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 42 | 119 | $214,200 | $21,664 | 10.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 48 | $22,560 | $3,256 | 14.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 27 | $18,360 | $2,755 | 15.0% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2023 | 13 | 13 | $18,725 | $1,300 | 6.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 56 | 137 | $246,600 | $25,459 | 10.3% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 14 | 43 | $34,400 | $4,041 | 11.7% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2022 | 25 | 25 | $34,825 | $3,146 | 9.0% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2022 | 16 | 16 | $28,000 | $2,406 | 8.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 39 | $18,330 | $2,367 | 12.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 34 | 78 | $140,400 | $15,462 | 11.0% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2021 | 32 | 32 | $34,050 | $2,356 | 6.9% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 16 | 16 | $23,400 | $1,674 | 7.2% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2021 | 12 | 12 | $19,800 | $1,547 | 7.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 39 | 84 | $151,200 | $16,087 | 10.6% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 15 | 15 | $20,400 | $1,492 | 7.3% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2020 | 14 | 14 | $17,250 | $1,237 | 7.2% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2020 | 12 | 12 | $18,300 | $1,133 | 6.2% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2020 | 13 | 13 | $15,150 | $1,012 | 6.7% |
About Dr. David Boldt, M.D
Dr. David Boldt, M.D is a Critical Care Medicine healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1124223565.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Boldt, M.D has received a total of $132,503 in payments from pharmaceutical and medical device companies, with $30,734 received in 2024. These payments were reported across 97 transactions from 2 companies. The most common payment nature is "Honoraria" ($95,164).
As a Medicare-enrolled provider, Boldt has provided services to 409 Medicare beneficiaries, totaling 743 services with total Medicare billing of $108,394. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Surgery, Surgical Critical Care
- Location Los Angeles, CA
- Active Since 06/16/2007
- Last Updated 12/23/2019
- Taxonomy Code 207LC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124223565
Products in Payments
- GIAPREZA (Drug) $132,261
- AVYCAZ (Drug) $29.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Los Angeles
Igor Barjaktarevic, M.d., M.sc, M.D., M.SC
Critical Care Medicine — Payments: $353,438
Critical Care Medicine $353,438
Dr. Scott Oh, D.o, D.O
Critical Care Medicine — Payments: $273,819
Critical Care Medicine $273,819
Tisha Wang, Md, MD
Critical Care Medicine — Payments: $45,715
Critical Care Medicine $45,715
Andrew Wachtel, M.d, M.D
Critical Care Medicine — Payments: $45,694
Critical Care Medicine $45,694
Frances Dy, Np, NP
Critical Care Medicine — Payments: $40,496
Critical Care Medicine $40,496
Christopher Newth, Md, MD
Critical Care Medicine — Payments: $29,227
Critical Care Medicine $29,227